Contact
Contact

Foreign Listings on U.S. Exchanges

Ready to Forge Your Growth in the U.S. Market?

You’re an overseas company ready to grow and kick off your journey to ringing the bell on a U.S. stock exchange. Each year many international companies consider going public in the U.S. for many reasons such as its global reach and large base of investment funds.

However, navigating all the Securities and Exchange Commission (SEC) requirements to do so can be a demanding and frustrating process. While undergoing a foreign listing in the U.S. can be easier than in other jurisdictions, there’s still a lot of work ahead of you to meet the registration, review, and foreign private issuer (FPI) requirements.

Your guide to doing business in the United States.

Download Centri’s Expert Guide
for doing business in the US

At Centri, our experts are here to relieve the burden on your team and help you be prepared for anything and everything that comes your way.

Meet Our Foreign Listings Leadership

Working with us gives you access to one firm with many experts, all united under the vision of our experienced leader. You can also learn more about our specialists on the One Team page.

Meet All Centri Experts
Gary Hanson headshot.

Gary Hanson

Senior Director

International Practice

Experts in Every Industry, Even the Complex Ones.

Technology Depending on your country’s regulatory frameworks, navigating U.S. securities laws can be a big hurdle. Doing the work to become compliant can require new systems, extensive internal audits, and new types of expertise outside of your current staffing. You’ll also need to overcome currency differences and cultural shifts as well. Centri can guide you through all of these complexities and also help you find the most efficient path forward. That way you don’t lose unnecessary time and money as you work on becoming a foreign private issuer.
Life Sciences Entering into the U.S. exchanges can be a costly endeavor and you don’t want it to take away from clinical trial funding or intellectual property protections you need to stay competitive. Plus, your company will need to adhere to new requirements, like stringent FDA guidelines for drug and medical device approval. And you’ll need to learn the cultural nuances of the healthcare market in the U.S. to set yourself up for success. With Centri’s help though, you don’t have to face it alone. Instead, you can leverage our experience in the life sciences industry and lean on our technical and up-to-date understanding of the latest requirements and regulations. Our team will guide you and ensure you’re prepared as you take these important steps toward a foreign listing.

How We Can Help:

Preparing for Your Transaction

  • Comprehensive project management sharing best practices and services.
  • Providing audit support for your PCAOB audit.
  • Valuations (409a, cheap stock, and other fair value considerations).
  • Conversion of accounting standards used for financial reporting (i.e., IFRS to U.S. GAAP and vice versa).
  • Assistance with preparing annual and interim financial statements.
  • Preparing technical accounting memorandums on relevant and various topics.
  • Support with tax structuring and computing the income tax provision and analyzing other relevant book-tax adjustments, including assessment under Section 382/383, to determine any limitations on the ability to utilize tax attributes pre- and post-IPO.

Filing Your Registration

  • Compiling due diligence documents for your working group.
  • Drafting the registration statement and assisting with MD&A, pro forma, and selected financial data.
  • Preparing Regulation S-X–compliant financial statements and footnotes.
  • Assisting with stock exchange listing requirements and associated applications for trading.
  • Supporting with tax-related items within the registration statements such as the accuracy of your tax basis balance sheet, which will be utilized to determine your deferred tax accounting.

Closing on Your Transaction

  • Compiling accurate and effective investor presentation decks. 
  • Advising on corporate structure and governance.
  • Drafting responses to SEC comment letters.
  • Performing a transaction cost analysis to determine costs incurred in connection with the IPO that are not deductible for tax purposes.

Ongoing Obligations

  • Assessing and implementing accounting and financial reporting technology.
  • Establishing a plan for Sarbanes-Oxley Act (SOX) compliance
  • Recurring financial reporting and regulatory filings.
  • Setting up an SEC reporting function.
  • Improving internal accounting policies and procedures to reduce financial statement close time.
  • Creating technical accounting research and position papers related to non-routine transactions.
  • Calculating your quarterly tax provision under ASC740.
  • Developing and maintaining a tax model that will help in planning, as well as the potential need for valuation allowances against deferred tax assets in your financial statements.
  • Calculating earnings and profits (E&P) to determine the tax characterization of future corporate distributions.
  • Develop or refine HR strategy, HR programming, and HR operating model to align and drive business results as a public company.
Business leaders in a meeting.

Looking For More Support?

Here are some other related services that can be helpful depending on the goals you have for your business.

Technical Accounting
Valuation
Audit Support

Need Our Foreign Listings Services?

Please fill in the form to get in touch with our team of advisory experts.

"*" indicates required fields

Name*
Join Our Mailing List

Related Insights